Results 251 to 260 of about 5,265,889 (366)
Objective Administrative claims are used to evaluate oral glucocorticoid use in rheumatoid arthritis (RA), despite limited evidence to support accuracy. We aimed to evaluate the performance of claims‐based algorithms for glucocorticoid use compared to self‐report in an RA population.
Beth I. Wallace+16 more
wiley +1 more source
Physics-informed machine learning digital twin for reconstructing prostate cancer tumor growth via PSA tests. [PDF]
Camacho-Gomez D+5 more
europepmc +1 more source
Molecular Physics: An Attempt at a Comprehensive Dynamical Treatment of Physical and Chemical Forces 1 [PDF]
George William De Tunzelmann
openalex +1 more source
Time Trends and Predictors of Gout Remission Over 6 Years
Objective This study aims to describe the trends in remission rates over 6 years of follow‐up among people with gout taking urate‐lowering therapy (ULT) and to identify variables that predict remission. Methods A post hoc analysis was conducted using data from the Cardiovascular Safety of Febuxostat or Allopurinol in Patients with Gout (CARES) trial ...
Adwoa Dansoa Tabi‐Amponsah+5 more
wiley +1 more source
Review Of Liquid Crystals: Fundamentals By S. Singh [PDF]
Collings, Peter J.
core +2 more sources
Objective We assessed whether shared decision‐making (SDM), and patient acceptability, feasibility, and overall satisfaction with a computerized patient decision aid (PtDA) for patients with systemic lupus erythematosus (SLE), differs by PtDA setting, modality, and the viewing experience.
Jasvinder A. Singh+3 more
wiley +1 more source
Objective Lupus low disease activity state (LLDAS) is a validated treatment target in systemic lupus erythematosus (SLE) but limited studies have explored the role of LLDAS in lupus nephritis (LN). This study aims to investigate the frequency and predictors of LLDAS attainment, and its benefit on LN relapse and renal function preservation in patients ...
Chak Kwan Cheung+6 more
wiley +1 more source
Correction to "CT scanning and questions about benefit versus risk". [PDF]
europepmc +1 more source